PACIRA PHARMACEUTICALS (PCRX) Covered Calls

PACIRA PHARMACEUTICALS covered calls

You can sell covered calls on PACIRA PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PCRX (prices last updated Fri 4:16 PM ET):

PACIRA PHARMACEUTICALS (PCRX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
46.35 +0.15 42.55 51.00 891K - 1.9B
Covered Calls For PACIRA PHARMACEUTICALS (PCRX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 47.5 1.45 49.55 -4.1% -41.6%
Nov 16 47.5 3.10 47.90 -0.8% -3.2%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company. It develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company markets EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic, indicated for administration into the surgical site to produce postsurgical analgesia; and DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a cancer of the immune system. Its product pipeline comprise EXPAREL that has completed Phase II clinical trials for postsurgical analgesia-nerve block administration; DepoNSAID, which is in preclinical trials for the relief of that is in preclinical trials acute pain; and DepoMethotrexate for the treatment of rheumatoid arthritis and oncology, as well as Bupivacaine Liposome Injectable Suspension for veterinary postsurgical analgesia. Pacira Pharmaceuticals was founded in December 2006 and is headquartered in Parsippany, NJ.